Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis by Mellone, Massimiliano et al.
 
 
 
 
                                                                                                                                                                    Research Paper 
 
www.aging-us.com 1 AGING (Albany NY) 
  
www.aging-us.com AGING 2016, Vol. 8, Advance   
 
Induction of fibroblast senescence generates a non-fibrogenic 
myofibroblast phenotype that differentially impacts on cancer 
prognosis 
 
Massimiliano Mellone1*, Christopher J. Hanley1*, Steve Thirdborough1, Toby Mellows1, Edwin 
Garcia1, Jeongmin Woo2, Joanne Tod1, Steve Frampton1, Veronika Jenei1, Karwan A. Moutasim1, 
Tasnuva D. Kabir3, Peter A Brennan4, Giulia Venturi1, Kirsty Ford1, Nicolas Herranz5, Kue Peng 
Lim6, James Clarke1, Daniel W. Lambert3, Stephen S. Prime7, Timothy J. Underwood1, 
Pandurangan Vijayanand8, Kevin W. Eliceiri9, Christopher Woelk2, Emma V. King1, Jesus Gil5, 
Christian H. Ottensmeier1, Gareth J. Thomas1 
 
1Cancer Sciences Unit, Faculty of Medicine, University of Southampton, SO166YD, UK 
2Faculty of Medicine, University of Southampton, Southampton SO166YD, UK 
3Integrated Biosciences, School of Clinical Dentistry, University of Sheffield, Sheffield S102TA, UK 
4Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth PO63LY, UK 
5MRC Clinical Sciences Centre, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, London 
W12, UK 
6Cancer Research Initiatives Foundation. Sime Darby Medical Centre, Subang Jaya, Selangor 47500, Malaysia 
7Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of Medicine 
and Dentistry, Queen Mary University of London, London E12AD, UK 
8La Jolla Institute for Allergy & Immunology, La Jolla, California 92037, USA 
9Laboratory for Optical and Computational Instrumentation (LOCI), Department of Biomedical Engineering, 
University of Madison, Wisconsin, WI 53706, USA 
*Contribute equally to this work 
 
Correspondence to: Gareth Thomas; email: g.thomas@soton.ac.uk 
Keywords: tumor microenvironment, myofibroblasts, senescence, collagen, extracellular matrix, senescent fibroblasts 
Received: August 10, 2016 Accepted: November 29, 2016 Published: December 15, 2016 
 
ABSTRACT 
 
Cancer-associated fibroblasts (CAF) remain a poorly characterized, heterogeneous cell population. Here we 
characterized two previously described tumor-promoting CAF sub-types, smooth muscle actin (SMA)-positive 
myofibroblasts and senescent fibroblasts, identifying a novel link between the two. Analysis of CAF cultured ex 
vivo, showed that senescent CAF are predominantly SMA-positive; this was confirmed by immunochemistry in 
head & neck (HNSCC) and esophageal (EAC) cancers. In vitro, we found that fibroblasts induced to senesce 
develop molecular, ultrastructural and contractile features typical of myofibroblasts and this is dependent on 
canonical TGF-β signaling. Similar to TGF-β1-generated myofibroblasts, these cells secrete soluble factors that 
promote tumor cell motility. However, RNA-sequencing revealed significant transcriptomic differences 
between the two SMA-positive CAF groups, particularly in genes associated with extracellular matrix (ECM) 
deposition and organization, which differentially promote tumor cell invasion. Notably, second harmonic 
generation imaging and bioinformatic analysis of SMA-positive human HNSCC and EAC showed that collagen 
fiber organization correlates with poor prognosis, indicating that heterogeneity within the SMA-positive CAF 
population differentially impacts on survival. These results show that non-fibrogenic, SMA-positive 
myofibroblasts can be directly generated through induction of fibroblast senescence and suggest that 
senescence and myofibroblast differentiation are closely linked processes.  
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INTRODUCTION 
 
Cancer-associated fibroblasts (CAF) have been shown 
to promote many, if not all, of the ‘hallmarks of malig-
nancy’ [1]. Despite their tumor-promoting properties, 
CAF remain a poorly-defined, heterogeneous cell 
population, possibly reflecting their cell(s) of origin, the 
tissue in which they develop, and their activation state 
[1-3]. No single marker reliably identifies all CAF, 
however, the most commonly analyzed sub-type have a 
contractile myofibroblastic phenotype, characterized by 
expression of α-smooth muscle actin (SMA) [4, 5]. 
While a number of signaling pathways contribute to 
myofibroblast transdifferentiation, complete transdif-
ferentiation requires both TGF-β1 signaling and 
mechanotransduction (i.e. increased tissue tension), 
mediated through Smad/Rho activation [6]. 
Myofibroblasts have been shown to promote tumor cell 
invasion and metastasis, and an SMA-positive, 
myofibroblast-rich stroma is prognostic in several 
cancers [7-10]. The motility-promoting effects of 
myofibroblasts result, at least in part, from their 
contractility and remodeling of collagenous extra-
cellular matrix (ECM) proteins, which serves to 
generate tissue tension and increased matrix stiffness [5, 
11]. ECM remodeling through thickening, linearization, 
elongation or crosslinking of collagen fibers, is common 
in cancers, and often found in areas where active cancer 
cell migration occurs [12-14]. However, recent studies 
have shown that there is a significant degree of 
heterogeneity in how CAFs interact with the ECM 
which influences disease progression [15, 16]. 
 
While CAFs are generally associated with having a 
myofibroblastic phenotype, recent research has 
identified a number of other CAF phenotypes [17, 18], 
including senescent CAF [19-21], which may also 
impact on tumor development and progression [19]. 
Senescence can be induced by a variety of intracellular 
and extracellular stimuli, including telomere 
dysfunction resulting from repeated cell division 
(replicative senescence) and DNA damage induced 
through oxidative or genotoxic stress (pre-replicative 
senescence) [22]. These stimuli induce Ataxia 
Telangiectasia Mutated kinase (ATM) to activate the 
DNA-damage response pathway to repair DNA 
damage. However, in the event of extensive, 
unrepairable DNA damage, cells undergo permanent 
growth arrest via p53/p21 or p16/pRB pathways [22]. 
Emerging evidence suggests that senescent CAF may 
also be tumor promoting [19-21], acquiring a 
senescence-associated secretory phenotype (SASP) that 
creates a permissive microenvironment favoring tumor 
development [20, 21, 23]. Notably, in fibrotic disease 
and wound healing, senescence of fibroblasts has been 
described as a mechanism for limiting fibrosis by 
suppressing ECM-production [24-26]. Whether 
fibroblast senescence functions similarly to limit 
collagen deposition in tumors has yet to be determined, 
but we have described previously varying ability for 
collagen fibrogenesis in CAF isolated from esophageal 
cancer [14]. 
 
In this study we analyzed human tumors and CAF 
cultured ex vivo, and found that senescent CAF are 
mostly SMA-positive. We compared the molecular and 
functional characteristics of TGF-β1-treated myo-
fibroblasts with fibroblasts induced to senesce through 
extended culture or various DNA damaging stimuli 
(irradiation, H2O2, cisplatin). Unexpectedly we found 
that, similar to TGF-β1 treatment, induction of 
fibroblast senescence generates an SMA-positive, 
contractile cell with molecular and ultrastructural 
features of a myofibroblast, and this is dependent on 
canonical TGF-β signaling. Transcriptomic analysis of 
TGF-β1-treated myofibroblasts and senescent fibro-
blasts revealed common gene expression related to 
contractile function, but with mostly divergent gene 
expression profiles. In particular senescent fibroblasts 
showed reduced ECM deposition and organization 
which affected cancer cell invasion. Bioinformatic and 
second harmonic generation analysis of these cells in 
vivo confirmed that there are significant differences in 
collagen production and structure within the tumor 
stroma. Moreover, in cohorts of patients with head & 
neck (HNSCC) and esophagus (EAC) cancer containing 
an SMA-positive stroma, the expression of collagen 
fibril organizing genes and the presence of an organized 
collagen matrix in the form of elongated collagen fibers 
is associated with the poorest prognosis. These results 
suggest that myofibroblast transdifferentiation and 
senescence are closely linked processes, whereby non-
fibrogenic myofibroblasts can be directly generated 
through induction of fibroblast senescence; this 
heterogeneity within the SMA-positive CAF population 
differentially impacts on patient survival. 
 
RESULTS 
 
Senescent CAF commonly co-express SMA ex vivo 
and in vivo 
 
To investigate the relationship between myofibroblast 
differentiation and fibroblast senescence, we cultured 
primary normal oral fibroblasts and CAF from human 
head and neck cancers (HNSCC) ex vivo and examined 
co-expression of SMA and SA-β-Gal (Fig. 1A). In 
normal fibroblasts there was a highly positive 
correlation between senescence and SMA expression 
(r2=0.82; Supplementary Fig. S1A); this correlation was 
weaker in CAFs (r2=0.32; Supplementary Fig. S1B), 
possibly suggesting greater heterogeneity in this 
fibroblast population.  
www.aging-us.com 3 AGING (Albany NY) 
  
 
 
Figure 1. Senescent CAF analyzed  ex vivo and in vivo are predominantly SMA-positive. (A) Histogram showing 
percentage of cells positive for senescence-associated (SA)-β-Galactosidase or SMA-positive stress fiber formation in normal oral 
fibroblasts (POF) and cancer-associated oral fibroblasts (CAF) grown ex-vivo. Data are presented as Mean ±SEM from 6 POFs and 6 
CAF. (B) Representative images of immunohistochemistry on sequential tissue sections of SMA-positive/p16-positive or SMA-
positive/p16-negative HNSCC cases. (C) Pie chart showing the percentage of HNSCC cases with stromal staining for SMA or p16. (D) 
Representative image of double immunofluorescence staining of a p16-positive/SMA-positive HNSCC case showing co-expression of 
SMA (red) and p16 (green, white arrows; scale bars represent 25µm). (E) Representative immunohistochemistry for SMA and 
markers of senescence (p53, p21) and oxidative stress (8-OHDG) on sequential tissue sections of HNSCC.  See also Supplementary 
Fig. S2. 
 
Table 1: SMA and p16 positive HNSCC cases.  
 SMA low SMA Mod/High 
p16 Mod/High 2 13 
p16 Low 40 41 
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To rule out the possibility of artefacts due to cell culture 
conditions, these  ex vivo observations were analyzed 
further using immunohistochemistry for markers of 
myofibroblast transdifferentiation (SMA) and 
senescence (p16) on HNSCC tissues (n=96). p16 and 
SMA were expressed in similar regions of the stroma 
(Fig. 1B) and, similar to CAF cultures ex vivo, most 
cases (87%; n=13/15) with p16-positive stromal 
staining also showed strong/moderate SMA positivity; 
conversely 76% of cases with strong/moderate SMA 
positivity did not express stromal p16 (41/54; Fig. 1C; 
Table 1). Co-expression of p16 and SMA was 
confirmed by dual immunofluorescence staining (Fig. 
1D). Since no single marker identifies senescent cells in 
tissues, we also examined expression of additional 
proteins associated with senescence (markers of cell-
cycle arrest and oxidative DNA damage; p53, p21 and 
8-OHdG respectively [22, 27, 28]) in 10 tumors with 
p16-positive/SMA-positive stromal cells, and found 
expression of these senescence markers in similar tissue 
areas in all cases (Fig. 1E). Similar findings were 
observed in esophageal cancer (EAC; n=21) with co-
expression of SMA/p53/p21 in 2/16 (12.5%) of the 
SMA-positive cases (Supplementary Fig. S1C and 
Supplementary Table S1). Thus a subset (ranging from 
12.5-24%) of tumors that contain SMA-positive stroma 
co-express markers of senescence. Conversely 
senescent CAF usually have an SMA-positive 
phenotype. 
 
Induction of fibroblast senescence generates a 
myofibroblastic phenotype 
 
The high proportion of SMA-positivity in the senescent 
fibroblast population in vivo raised the possibility that 
the induction of senescence may promote myofibroblast 
differentiation. To investigate this in vitro we used 
human fetal foreskin fibroblasts (HFFF2), induced to 
senesce using different stimuli (irradiation, H2O2, 
replicative senescence, cisplatin) or treated with TGF-
β1, to promote myofibroblast phenotype. Senescence 
was confirmed by increased expression of senescence 
markers SA-β-Galactosidase (SA-β-Gal; Fig. 2A), 
pH2AX and p21 (Supplementary Fig. S2A) and 
decreased proliferation rates (Fig. 2B). Myofibroblast 
transdifferentiation was confirmed by SMA-positive 
stress fiber formation (Fig. 2C), and upregulation of 
SMA, palladin and phospho-FAK (Fig. 2D). Notably 
we observed that, similar to TGF-β1 treatment, 
fibroblasts induced to senesce by different stimuli 
formed SMA-positive stress fibers (Fig. 2C) and 
showed increased expression of classical myofibroblast 
markers (Fig. 2D). SMA co-localized with SA-β-gal 
expression in senescent cells (Supplementary Fig. S2B), 
correlated with senescence in a dose-dependent manner 
following H2O2 treatment (Supplementary Fig. S2C) 
and was impaired by inhibition of the DNA-damage 
response pathway via a specific inhibitor of ATM 
(Supplementary Fig. S2D). Ultrastructural analysis 
confirmed that senescent fibroblasts contained abundant 
rough endoplasmic reticulum and bundles of 
submembranous microfilaments consistent with a myo-
fibroblastic phenotype (Fig. 2E). These observations 
were reproduced in primary fibroblasts isolated from 
normal oral mucosa, skin and colon (Fig. 2F-H), and 
also using cisplatin as a further stimulus of senescence 
(Supplementary Fig. S2E, F). Similar to TGF-β1-treated 
HFFF2, SMA-positive cells generated through 
senescence were contractile (Fig. 2H) and supported 
Transwell migration of tumor cell lines from cancers of 
the head and neck (HNSCC, 5PT) and esophagus (EAC, 
OE33) (Fig. 2I). These data show that senescent 
fibroblasts develop a contractile myofibroblast-like 
phenotype similar to TGF-β1 treatment, which is 
consistently observed across multiple senescence 
stimuli and in primary fibroblasts isolated from 
different tissues. 
 
Senescence stimuli induce a myofibroblastic 
phenotype through activation of SMAD signaling 
 
Canonical TGF-β/Smad signaling plays a pivotal role in 
myofibroblast differentiation [6] and has also been 
shown to play a role in senescence induction [22]. To 
investigate the molecular mechanism regulating 
senescence-induced myofibroblast differentiation we 
examined Smad activation following senescence 
induction through irradiation. Similar to TGF-β1 
treatment, irradiation increased phospho-Smad2/3 
protein levels and its nuclear localization (Fig. 3A-C). 
Other senescence-inducing stimuli (replicative 
senescence, H2O2) similarly activated Smad signaling 
(Supplementary Fig. S3A). Inhibiting TGF-β signaling 
using siRNA knockdown of Smad3, a pan-TGF-β 
antibody or a specific inhibitor of TGF-β receptor 1 
(TGF-βR1) kinase activity suppressed SMA upregula-
tion by irradiation and H2O2 (Fig. 3D, E; Supplementary 
Fig. S3B-D). We also found that irradiated fibroblasts 
have enhanced ability to activate TGF-β1, which may 
play an important role in driving myofibroblastic 
transdifferentiation in adjacent cells (Fig. 3F). These 
data show that induction of senescence activates 
canonical TGF-β1 signaling which promotes 
myofibroblast transdifferentiation. 
 
Transcriptomic analysis of myofibroblasts induced 
through TGF-β1 or senescence 
 
Due to their functional and molecular similarities, we 
next compared the transcriptomic profiles of HFFF2 
fibroblasts treated with either TGF-β1 or irradiation, 
cultured for 7 days and analyzed by RNA-sequencing.  
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Figure 2. Induction of fibroblast senescence generates a myofibroblastic phenotype. HFFF2 fibroblasts were induced to 
senesce through serial passaging (RS), treatment with γ-irradiation (10Gy; IR) or H2O2 (1mM). Cells were treated with TGF-β1 
(2ng/ml) for 72 hours to induce myofibroblast transdifferentiation as a positive control. 4-6 days post stimuli, induction of 
senescence was confirmed by (A) expression of SA-β-Galactosidase (SA-β-Gal; Scale Bar indicates 100µm) and (B) proliferation 
assays (cell counts presented as percentage of cells compared to untreated control cells; see also Supplementary Fig. S2A). Cells 
were examined for myofibroblast features: (C) Representative images of immunofluorescence for SMA expression (green) with DAPI 
nuclear counterstain (Blue) (Scale Bar indicates 100µm); (D) Western blotting for SMA, palladin and pFAK (HSC-70 as loading 
control); (E) Representative images of transmission electron microscopy. Arrows highlight sub-membranous microfilaments (Scale 
Bar indicates 50nm). (F-H) Western blotting for SMA expression (HSC-70 as loading control) and SA-β-Gal quantification following 
TGF-β1- and irradiation of primary fibroblasts isolated from oral, skin and colonic mucosa respectively. (I) Representative images of 
collagen gel contraction assays following treatment of HFFF2 with TGF-β1 or different senescence-inducing stimuli. Histogram 
shows quantification of gel area expressed as the mean ± SEM of 4 replicates; (J) Transwell migration assays with HNSCC (5PT) and 
EAC (OE33) cell lines. Conditioned media (CM) from HFFF2 fibroblasts induced to senesce through γ-irradiation (10Gy; IR) or to 
transdifferentiate into myofibroblasts through TGF-β1 was used a chemoattractant in the lower chamber. Data are presented as 
mean ± SEM and statistics are shown for T-test compared to controls (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). See also 
Supplementary Fig. S1. 
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Gene Set Enrichment Analysis confirmed that the 
expression profiles of the treatments matched TGF-β1 
and senescent gene signatures described previously 
([29, 30] respectively; Supplementary Fig. S4A-B). 
Given the functional and molecular similarities 
identified in the earlier experiments, we were surprised 
that unsupervised hierarchical clustering of significant 
differentially expressed genes (DEGs; FDR adj. 
p<0.001; Supplementary File 1) clearly discriminated 
between the subgroups; this highlighted a relatively 
small number of genes commonly up-regulated (5.7%) 
or downregulated (12.5%) (Fig. 4A, B), including 
ACTA2 (SMA). We confirmed the RNA-sequencing 
results using real-time PCR, focusing on genes known 
to be up-regulated in myofibroblasts and senescent 
fibroblasts. Notably, genes associated with ECM 
deposition and manipulation (COL1A1/1A2/3A1, FN1 
and MMP2)[31] (Fig. 4C), were only significantly 
upregulated in TGF-β1-induced myofibroblasts. 
Conversely, senescence markers (CDKN1A/p21 and 
SERPINE1/PAI-1) [32] were primarily up-regulated in 
irradiated cells (Fig. 4D). We confirmed that ACTA2 
was up-regulated in both subgroups (Fig. 4E). 
 
We used Gene Set Enrichment Analysis to determine 
the gene ontology terms associated with the TGF-β1 
and irradiated transcriptomes. This showed that TGF-
β1-treated fibroblasts up-regulate a number of genes 
associated with ECM deposition/manipulation, muscle 
development and proliferation, consistent with a 
classical myofibroblast phenotype. Comparatively, 
irradiated fibroblasts up-regulated genes associated with 
contractility, but no GO terms related to ECM 
deposition/manipulation were identified (Table 2 and 
 
 
Figure 3. Smad signaling mediates senescence induction of a myofibroblastic phenotype. Western blot showing SMA 
and phospho(p)-Smad2/3 expression following treatment of HFFF2 fibroblasts with TGF-β1 (A) or irradiation (B) (Smad2 and HSC-70 
as loading controls). (C) Representative images of immunofluorescence on HFFF2 fibroblasts showing expression of SMA (green), 
pSmad2/3 (red), SA-β-Galactosidase activity (grey; in bright field) with DAPI nuclear counterstain (Blue) (scale bar indicates 100µm). 
(D) Western blots showing SMAD3 knock-down (Tot-FAK as loading control) (left) and SMA expression (HSC-70 as loading control; 
right) in irradiated HFFF2 cells. (E) Western blot for SMA expression in irradiated HFFF2 pre-treated with a pan TGF-β1 inhibitory 
antibody. (F) TGFβ-1 assay showing luciferase activity controlled by a TGFβ-1 responsive promoter in MLEC cells co-cultured for 24 
hours with untreated or irradiated fibroblasts (y axis indicates the ratio between luciferase activity and HFFF2s protein 
concentration). Data are presented as mean ± SEM and statistics are shown for T-test compared to controls. See also 
Supplementary Fig. S3. 
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Supplementary Table S2 for the full list of GO 
categories). These data show that while TGF-β1-driven 
myofibroblasts and senescent fibroblasts share common 
genes associated with cell contractility, the phenotype 
associated with ECM production/remodeling is specific 
to the TGF-β1-treated cells. 
 
Senescence-induced myofibroblasts develop a non-
fibrogenic phenotype in vitro and in vivo  
 
The difference in ECM related gene expression, 
between TGF-β1 treated and irradiated fibroblasts, was 
clearly demonstrated by analysis of genes within the 
core ‘Matrisome’ ([33]; consisting of fibronectin, 
proteoglycans and collagens, among other ECM 
associated genes). These genes were predominantly up-
regulated in TGF-β1-treated fibroblasts and 
downregulated in irradiated fibroblasts (Supplementary 
Fig. S4C). Consistent with these findings, in vitro 
analysis of fibroblast-derived matrices (FDMs) showed 
that TGF-β1-treated fibroblasts produced a dense 
fibronectin matrix composed of mature fibrils; whereas 
irradiated fibroblasts produced minimal matrix (Fig. 
5A-B). In contrast to Transwell assays using fibroblast 
conditioned medium (showing that both TGF-β1 and 
irradiated myofibroblasts secrete factors that promote 
 
 
Figure 4. Senescence- and TGF-β1-induced myofibroblasts have divergent gene expression profiles. (A-B) RNA-
sequencing analysis of HFFF2 cells treated with TGF-β1 (2 ng/ml) or irradiation (10Gy) and grown for 7 days. (A) Unsupervised 
hierarchical clustering of the expression levels of differentially expressed genes (DEGs; FDR adj. p<0.001), identified using GLM 
likelihood ratio testing. Expression levels were subjected to Z score scaling within each sample for visualization purposes. Distances 
were calculated using a Euclidean distance measure. (B) Venn diagram showing the number of DEGs up- or downregulated in TGF-
β1 and irradiated fibroblasts compared to controls. (C-E) RT-PCR measurements of mRNA expression levels of genes associated with 
myofibroblasts (C, E) and senescence (D) in HFFF2 cells used in the RNA-sequencing. Data are presented as mean ±SEM and 
statistics are shown for t-tests compared to control group. See also Supplementary Fig. S4. 
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tumor cell migration; Fig. 2J), tumor cells showed 
significantly increased invasion only through matrices 
secreted by TGF-β1-treated fibroblasts (Fig. 5C), 
suggesting that this ECM differentially promotes cancer 
cell invasion. 
 
As collagens are a major constituent of tumor ECM, we 
next interrogated the RNA-sequencing dataset to 
examine expression of collagen superfamily genes (Fig. 
5B-C). These genes were predominantly upregulated by 
TGF-β1 and down-regulated following irradiation 
(Supplementary Fig. S4D; complete lists are provided in 
Supplementary Table S3). Notably, there was complete 
divergence in the expression of fibrillar collagens (each 
being up-regulated by TGF-β1 and down-regulated by 
irradiated fibroblasts) (Fig. S4E). This was also 
confirmed at the protein level by Western blotting and 
immunofluorescence (Supplementary Fig. S4F and G). 
To test the in vivo ability of SMA-positive fibroblasts, 
generated either through TGF-β1 treatment or 
senescence induction, to produce and remodel 
collagenous ECM, we used a HNSCC cancer xenograft 
model (5PT) [34], co-injecting tumor cells with TGF-
β1-treated or irradiated fibroblasts. Consistent with our 
earlier observations, both fibroblast subgroups 
generated an SMA-positive tumor stroma (Fig. 5D). 
However the analysis of collagen deposition and fiber 
organization by Masson’s Trichrome staining and 
Second Harmonic Generation imaging on the mouse 
tumors showed that TGF-β1 treated fibroblasts 
generated significantly more collagen with elongated 
fibers compared to irradiated fibroblasts (Fig. 5E-F). 
This evidence suggests that although senescent 
fibroblasts display a SMA-positive contractile 
phenotype they have reduced ability to deposit 
collagenous ECM.  
Table 2: Top 5 GO terms with significant enrichment of TGF-β1-up or IR-up DEGs, identified by Gene Set 
Enrichment Analysis. 
TGF-β1 Up-regulated     
GO TERM SIZE NES NOM p FDR q 
PROTEINACEOUS EXTRACELLULAR MATRIX 72 2.001 <0.001 0.067 
EXTRACELLULAR MATRIX 73 1.998 <0.001 0.035 
SKELETAL DEVELOPMENT 71 1.902 <0.001 0.094 
INTERPHASE OF MITOTIC CELL CYCLE 57 1.846 <0.001 0.140 
DNA REPLICATION 95 1.817 <0.001 0.159 
     
Irradiation Up-regulated     
GO TERM SIZE NES NOM p FDR q 
CONTRACTILE FIBRE PART 15 2.149 <0.001 0.013 
CONTRACTILE FIBRE 16 2.067 <0.001 0.021 
REGULATION OF PROTEIN AMINO ACID 
PHOSPHORYLATION 
18 1.893 <0.001 0.117 
EXTRINSIC TO MEMBRANE 15 1.870 <0.001 0.111 
STRUCTURAL CONSTITUENT OF MUSCLE 18 1.821 0.013 0.161 
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Figure 5. Myofibroblasts and not senescent fibroblasts mediate collagenous ECM deposition. (A) Schematic of 
experimental procedure for B and C. (B) Representative image of immunofluorescent staining for Fibronectin (FN) in fibroblast-
derived matrices (FDM) produced by HFFF2s treated as indicated; FN (orange; pseudo-colored in Fiji) and Dapi (blue) as nuclear 
counterstain; scale bar represents 50µm. (C) Transwell assay examining OE33 invasion through FDM deposited by HFFF2 fibroblasts 
induced to transdifferentiate through treatment with TGF-β1 or γ-irradiation (IR). (D-F) Analysis of xenografts formed from 5PT cells 
injected s.c. into RAG1-/- mice with HFFF2 fibroblasts treated as indicated. (D) Representative images of SMA immunochemistry in 
5PT xenografts co-injected with HFFF2s treated as indicated. Histogram shows SMA quantification expressed as % positive area. (E) 
Representative images of Masson’s trichrome staining for collagen (royal blue) with HFFF2s treated as indicated. Histogram shows 
quantification expressed as % positive area. (F) Representative images showing multi-photon excitation (MPE) filtered for second 
harmonic generation to identify collagen fibers on sections from the xenograft tumors as indicated (Scale Bar indicates 100µm). 
Histogram shows quantification of collagen fiber elongation. Data are presented as mean ± SEM and statistics are shown for T-test 
compared to controls unless otherwise indicated.  
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Analysis of ECM in human tumors in relation to 
myofibroblast subsets, and association with patient 
survival 
 
To determine the association between senescent-
myofibroblasts or TGF-β-myofibroblasts and gene 
expression in human tumors we applied weighted gene 
co-expression network analysis (WGCNA) to the 
Cancer Genome Atlas HNSCC RNA-sequencing 
dataset (TCGA Network, 2015) [35]. This systems 
analysis of gene co-expression allowed us to extract 
information on cell-specific biological processes 
occurring in whole tissue of 246 HNSCC cases 
identifying twelve modules of highly co-expressed 
genes (Fig. 6A) [36]. These included an ECM module 
significantly enriched with collagen superfamily genes 
(brown color, ECM module; GO: ECMO; see 
Supplementary File 2 for the GO analysis; Fig. 6A-B) 
 
 
Figure 6. Collagen fiber deposition impacts tumor progression.  (A) Gephi network graph where each node represents a 
gene labelled by color according WGCNA module assignment. Distance between nodes is represented by the TOM connectivity 
measure. The brown module is the ECM module. (B) ECM module extracted from panel A. (C) Network graph of the ECM module 
where nodes are color coded according to the correlation with TGF-β1-up DEGs, summarized by a signature eigengene. Red and 
blue colors show positive and negative correlation, respectively. (D) Correlation of IR-up DEGs with members of the ECM module 
(color range described above). (E-F) Kaplan-Meier curves showing survival rates in HNSCC patients with greater than average 
expression of genes associated with myofibroblasts stratified for COL3A1 (E) and CFOG expression (F). (G) Kaplan-Meier curves 
showing disease specific survival (DSS) rates in HNSCC patients with moderate or high stromal SMA expression (measured by 
immunohistochemistry), stratified by collagen fiber elongation measured by Second Harmonic Generation imaging. See also 
Supplementary Fig. S5. 
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[36]. The ECM module correlated well with TGF-β1-up 
DEGs derived from our in vitro RNA-sequencing 
analysis (KME=0.94, p≤2.2E-16) and with a publicly 
available TGF-β1 geneset used in Supplementary Fig. 
S4A (KME=0.529, p<2.2E-16) (Fig. 6C and 
Supplementary Fig. S5A, respectively). However, there 
was no or weak correlation between the ECM module 
and irradiation-up DEGs (KME=-0.022, p=0.631) or 
with the senescence geneset used in Supplementary Fig. 
S4B (KME=0.103, p=0.023) (Fig. 6D and 
Supplementary Fig. S5B). Consistent with this, collagen 
superfamily genes showed a strong positive correlation 
with the TGF-β1 gene signature, but not the irradiation-
gene signature (e.g. COL1A1-TGF-β1 r=0.92 and 
COL1A1-irradiation r=0.23; Supplementary Fig. S5C 
and Supplementary Table S4). Analysis of fibrillar 
collagen structure in human HNSCC stroma confirmed 
the correlation observed in the bioinformatics analysis 
between ECM production and a myofibroblastic non-
senescent stroma: p16-negative/SMA-positive tumors 
displayed elongated collagen fibers which were absent 
in the p16-positive/SMA-positive stroma (Supple-
mentary Fig. S5D-F). Overall, these data suggest that 
ECM production and organization are restricted to 
CAFs with non-senescent myofibroblastic phenotype 
and not found in senescent CAFs. 
 
We have shown previously that a myofibroblastic 
SMA-positive stroma is associated with poor survival in 
HNSCC and EAC [8, 10], but the results above describe 
heterogeneity within this population, particularly in the 
ability to produce collagenous ECM. We tested whether 
this related to patient survival rates using the HNSCC 
CGA cohort. The cohort was divided into two based on 
the mean expression of genes associated with 
myofibroblasts (ACTA2, CDH2, PDGFRA, PDGFRB, 
VIM, S100A4) to examine the prognostic significance 
of the ECM module hub gene COL3A1 (the most 
connected gene, representative of the ECM module 
expression) within HNSCC cases with a 
myofibroblastic stroma; this analysis showed COL3A1 
expression is associated with poor survival (Log Rank 
p=0.019; Fig. 6E). We previously identified a cluster of 
collagen fibril organizing genes (CFOG: COL1A1, 
COL1A2, COL3A1, P4HA1, LOX, LEPRE1, ANXA2, 
TNXB, PLOD3, SERPINH1) up-regulated in a 
fibrogenic sub-set of SMA-positive CAFs [14]. High 
expression of this gene signature was also associated 
with poor prognosis in the SMA-positive HNSCC 
patient group (Log Rank p=0.003; Fig. 6F). 
 
Finally we used Second Harmonic Generation imaging 
to analyze fibrillar collagen in the tumor stroma of 
HNSCC and EAC patient cohorts selected for 
moderate/high stromal SMA expression [14]. This 
showed that the presence of elongated collagen fibers 
was significantly prognostic for both tumor types (Log 
Rank p=0.027 & 0.028 respectively; Fig. 6G, 
Supplementary Fig. 5G & Supplementary Tables S5 and 
S6). These data indicate that, within the myofibroblastic 
CAF population, the ‘classical’ matrix-producing 
phenotype is associated with the poorest survival. 
 
DISCUSSION 
 
While numerous markers, such as PDGFRα, periostin 
and fibroblast activation protein (FAP) have been 
reported to identify CAF within the tumor 
microenvironment [37], SMA is most commonly used 
to identify those CAF with an ‘activated’ tumor-
promoting myofibroblastic phenotype. The importance 
of SMA-positive CAF in tumor progression is 
highlighted by the poor survival rates of patients with 
this type of tumor stroma, with contractile cells likely to 
actively contribute to tumor progression through 
generating increased tissue tension and promoting 
tumor cell mechanotransduction, invasion and 
metastasis [11-13, 38, 39]. Indeed, the degree of in vitro 
myofibroblast contractility has been shown to correlate 
with tumor promotion in vivo [2], and studies using 3D 
model systems have shown that mechanical re-
modelling of the ECM through cellular contraction is a 
requirement for cancer cell invasion [8, 39]. 
 
Similar to myofibroblastic CAF, senescent CAF have 
also been shown to be tumor promoting in model 
systems [19-21]; although few studies have examined 
their frequency, prognostic significance or relationship 
to myofibroblastic CAF in human tumors [40]. 
Senescence has been shown to limit the progression of 
myofibroblast-dependent tissue fibrosis [24-26], and 
suggestions have been made that myofibroblast 
differentiation and senescence reflect a unified program 
of fibroblast differentiation. Consistent with this, we 
found that senescent CAF in different tumor types are 
mostly SMA-positive. Although CAFs are sometimes 
considered to be highly proliferative cells, we found 
that CAF isolated from HNSCC, and cultured ex vivo, 
show senescent features, which correlate with SMA 
positivity [41]. Notably, here we show that induction of 
fibroblast senescence generates an SMA-positive 
contractile cell with ultrastructural myofibroblastic 
features. However, despite TGF-β1-induced and 
senescence-induced myofibroblasts having similar 
contractile and functional features, there are major 
differences in their gene expression profiles, clearly 
observed in the expression of genes associated with 
ECM deposition and organization, suggesting that these 
cells generate significantly different microenvironments 
during tumor progression. Proteomic analysis of SMA-
positive CAF isolated from EAC has previously 
highlighted variations in collagen gene expression [14]; 
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our current study suggests that this may be due to a 
variably senescent phenotype.  
 
Transwell experiments show that both types of SMA-
positive CAF secrete factors that promote tumor cell 
motility, although these are mostly different. For 
example, analysis of RNA sequencing data from SMA-
positive cells generated through either TGF-β1 
treatment or senescence-induction revealed contrasting 
upregulation of numerous matrix and soluble factors 
reported previously to promote tumor invasion (eg. 
TGF-β1 treatment - IGF1, PDGF-A, VEGF-A, MMP-2, 
POSTN (periostin); senescence induction – SPP1 
(Osteopontin), CXCL14, FGF1, EGF, MMP-12; all 
p<0.001); we recently found that suppression of the 
SASP in senescent fibroblasts through mTOR inhibition 
abrogates this invasion-promoting effect [42].  
 
Induction of SMA expression and cell contractility 
following various senescence stimuli was dependent on 
TGF-β/Smad signaling. This is consistent with previous 
studies indicating that radiation and reactive oxygen 
species can activate latent TGF-β1 [43]. Conversely we, 
and others, have also observed that TGF-β/Smad 
pathway is crucial for induction of senescence [41, 44, 
45], suggesting a degree of overlap between the 
molecular mechanism(s) regulating myofibroblast 
differentiation and senescence. RNA-sequencing data 
showed that senescent fibroblasts are characterized by 
reduced ECM deposition, and previous studies on liver 
fibrosis and skin wound healing have indicated that 
myofibroblasts, whilst initially proliferating and 
producing ECM, are themselves eventually driven into 
senescence and cleared by the immune system, thereby 
self-limiting fibrogenesis [24, 25]. The matricellular 
protein CCN1 has been shown to restrict fibrosis in 
senescent fibroblasts [25]; consistent with this, our 
RNA sequencing analysis revealed CCN1 upregulation 
in senescent, SMA-positive myofibroblasts generated 
through irradiation (p=0.003). Thus myofibroblast 
differentiation and fibroblast senescence may form part 
of a dynamic spectrum of fibroblast responses found at 
different stages along the same regulatory program, and 
it is possible that the pathological accumulation of 
SMA-positive, ECM-producing myofibroblasts in 
cancers and progressive fibrosis may result from an 
ongoing process of senescence evasion or continuous 
myofibroblast repopulation. 
 
Survival analysis of cohorts of patients with HNSCC 
and EAC showed that collagen deposition and structure 
is significantly prognostic, and adds a further layer of 
stratification in patients with tumors containing an 
SMA-positive stroma. While most studies have shown 
that senescent fibroblasts are generally tumor 
promoting, this being linked to secreted factors within 
the SASP, within the SMA-positive CAF population 
they can be regarded as the lesser of two evils. It 
remains to be addressed whether the difference in 
prognosis between the SMA-positive CAF subgroups is 
due to deposition/reorganization of collagenous matrix; 
it is possible that the presence of a collagen-rich ECM is 
simply a surrogate for identifying the presence of cells 
with a ‘conventional’ myofibroblast phenotype. Further 
studies are required to examine whether the ECM 
remodeling capability or the secretory program of 
myofibroblastic CAFs has the strongest impact on 
tumor progression. However, our Transwell assays 
show that while TGF-β-driven myofibroblasts promote 
tumor cell motility by secreting factors and 
manipulating ECM, senescent fibroblasts lack the latter 
property. Several studies suggest mechanisms through 
which collagen may promote cancer progression; 
generating a stiff ECM that activates integrin-dependent 
mechanotransduction pathways and promotes cell 
motility [38]; providing aligned tracks that guide and 
facilitate cancer cell movement and dissemination [46]. 
Consistent with these reports, collagen structure has 
been shown to be prognostic in breast cancer [47, 48] 
and increased expression of type I collagen and related 
genes is frequently observed in the gene expression 
signatures associated with increased risk of metastasis 
[49].  
 
In summary, these data describe a common link 
between myofibroblast differentiation and senescence. 
Senescent fibroblasts represent a distinct subgroup of 
cells within the SMA-positive, myofibroblastic CAF 
population, sharing a contractile phenotype but not the 
ability to generate an organized collagenous ECM. This 
latter feature predicts for outcome in cancer patients, 
improving prognostic stratification and refining 
characterization of the activated ‘myofibroblastic’ 
phenotype.  
 
MATERIALS AND METHODS 
 
Analysis of human tumors 
 
Appropriate ethical and institutional approval to work 
with human tissues was obtained. Tissue microarrays of 
head & neck cancers (HNSCC) [8] and esophageal 
adenocarcinoma (EAC) [10] were constructed from 
archival paraffin-embedded material at University 
Hospital Southampton using triplicate, randomly-
selected 1mm cores (Alphelys MiniCore 3). Scoring for 
SMA and p16 staining was carried out independently 
(GJT, KM, TU; blinded to clinical outcome) using a 
semi-quantitative scoring system [8], according to the 
extent of stromal positivity (low/negative [<5% stroma 
positive], moderate [patchy/focal expression, 5–50% 
stroma positive], high [diffuse expression throughout 
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tumor, >50% stroma positive]). Immunohistochemistry 
methodology is described in online Supplementary 
Materials. 
 
Cell Culture  
 
Human EAC cell line OE33, and human fetal foreskin 
fibroblasts HFFF2 were purchased from European 
Collection of Cell Cultures (Public Health England); 
HNSCC 5PT [34] was provided by I. Mackenzie 
(Queen Mary University of London). Mink lung 
epithelial cells (MLEC) stably expressing a TGF-β1-
responsive luciferase reporter construct were provided 
by D. Rifkin (New York University); HFFF2 cells, 
MLEC and human primary fibroblasts isolated ex vivo 
were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% FBS and 292μg/ml 
L-Glutamine. OE33 were cultured in RPMI-1640 
medium supplemented with 10% FBS and 292μg/ml L-
Glutamine. 5PT were cultured in keratinocyte growth 
medium [50]. HFFF2 and human primary fibroblasts 
were used at early passage (1-10; see online 
Supplementary Material for primary fibroblasts 
isolation). All cells were cultured using standard 
polystyrene cell culture plates/flasks (Corning). HFFF2 
cells were transfected with SMAD3 On-Target pool 
siRNA (Thermo Scientific/ Dharmacon) using 
Oligofectamine reagent (Life Technologies) as 
described [51]. TGF-β1 (R&D Systems; 2ng/ml for 3 
days) was used to induce myofibroblast differentiation 
unless otherwise stated. TGF-βR1 inhibitor (1µM; 
Calbiochem), TGF-β1-2-3 antibody (10µg/ml; 
MAB1835, R&D Systems) or ATM inhibitor KU-
55933 (20µM; Millipore) were added to cells 2-hours 
prior to TGF-β1 treatment. Conditioned medium (CM) 
was prepared over 72 hours as described previously [50] 
from cells treated with TGF-β1 or with senescence-
inducing stimuli, and used as a chemoattractant in 
Transwell migration assays [52] (online Supplementary 
Materials). 
 
Senescence induction 
 
To induce replicative senescence, fibroblasts were 
serially passaged (to passage 50) and senescence 
confirmed as described below. To induce pre-replicative 
senescence confluent pre-senescent fibroblasts were 
detached and irradiated in suspension with 10Gy γ-rays 
(1-2 cycles of 10Gy) and plated at sub-confluent 
densities [53]; otherwise adherent, fibroblasts were 
treated with either 1mM H2O2 or 10µM Cisplatin, and 
re-plated after 24 hours at sub-confluent densities.  
Cells acquired a fully senescent phenotype 4-6 days 
post-treatment, confirmed by determining the 
percentage of SA-β-Gal-positive cells (Sigma) with 
cells counterstained with DAPI [54]. At least 200 
cells/well in duplicate were counted per sample. 
 
Second Harmonic Generation Microscopy 
 
Fibrillar collagen was imaged using a custom-built two-
photon laser scanning microscope at the Laboratory for 
Optical and Computational Instrumentation (LOCI) 
University of Wisconsin-Madison; and quantitatively 
analyzed using the ctFIRE software package 
(http://loci.wisc.edu/software/ctfire) [48, 55]. Measu-
rement of collagen fiber elongation is described in 
online Supplementary Material.  
 
In vivo experiments  
 
Investigation on mice has been conducted in accordance 
with the ethical standards and according to the 
Declaration of Helsinki and according to national and 
international guidelines and has been approved by the 
authors' institutional review board and by the Home 
Office. Xenograft model: 1x106 5PT cells [34] ± 3x106 
HFFF2 cells were re-suspended in 150µl of supplement 
free DMEM; 100µl of this mix was injected s.c. in the 
flank of partially immunocompromised, male, RAG1-/- 
C57BL/6 mice. Animals were culled after 5-6 weeks of 
tumor growth and tumors processed to paraffin. At least 
5 animals were used per group. Quantification of SMA 
and Masson’s Trichrome (collagen) staining in 
xenograft tumors was carried out using color 
thresholding in Fiji. 3-5 independent, randomly 
selected, fields of view were analyzed for each tumor in 
order to generate a mean value per tumor, which was 
compared between treatment groups. 
 
RNA-sequencing  
 
HFFF2 were treated 7 days prior to RNA extraction, 
RT-PCR and RNA-sequencing analysis. RNA-
sequencing libraries were prepared for each RNA 
sample, sequenced using an Illumina HiSeq 2500 
platform (see online Supplementary Materials). FDR 
adj. p<0.001 was used to determine expression levels of 
differentially expressed genes (DEGs) (see 
Supplementary Material for full list of DEGs). Gene Set 
Enrichment Analysis was performed using the Broad 
Institutes GSEA tool with gene lists pre-ranked by log 
fold-change (http://www.broadinstitute.org/gsea/).  
 
Bioinformatic analysis 
 
Data acquisition and processing 
CEL files were imported from the HNSCC dataset from 
Cancer Genome Atlas Network [35] into the 
R/Bioconductor package ‘limma’ and normalized using 
the voom algorithm [56, 57]. Outlier subjects were 
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identified and excluded using a sample network 
connectivity statistic described previously [58] and 
implemented in the R function SampleNetwork. 
 
Weighted Gene Co-expression Analysis (WGCNA) 
WGCNA is a systems data mining method used for 
studying gene co-expression networks based on 
pairwise correlations between variables., and was 
performed using the WGCNA package in R[58]. This 
was used to extract information on cell-specific 
biological processes occurring in whole tumor tissue of 
246 HNSCC cases (Cancer Genome Atlas Network) 
[35]. The power of WGCNA in capturing a systems 
perspective is built upon its underlying algorithm, 
which takes into account not only the correlation of two 
genes with each other but also the degree of similarity 
between a pair of genes in their correlation structure 
within the rest of the network [36]. Briefly, a signed 
correlation matrix was obtained by calculating the 
weight mid-correlations between all variable probe sets 
across all samples. Next, the adjacency matrix was 
calculated by raising the absolute values of the 
correlation matrix to a power of 12. For computational 
reasons, topological overlap (TO) was then calculated 
for the 4000 most connected genes (among the 9925 
most varying annotated probe sets) across 246 samples. 
Finally, genes were hierarchically clustered using 1-TO 
(topological overlap) as the distance measure and 
twelve differently colored modules were determined 
using a dynamic tree-cutting algorithm. To establish 
whether the gene co-expression modules reflect cell 
types or biological processes, a Gene Ontology (GO) 
analysis was conducted using the ToppGene 
bioinformatics suite [59]. To determine if the network 
was reproducible across datasets, we evaluated that the 
module density and connectivity patterns defined in the 
CGA RNA-sequencing dataset were preserved in two 
independent HNSCC cohorts [60, 61] both analyzed 
with Affymetrix HG-U133 Plus 2.0 microarrays. 88.9% 
of the 4000 genes used to construct the aforementioned 
network were preserved in the array data. The relative 
affiliation (Membership) of any gene or gene group to 
the ECM module was estimated by correlating its 
expression profile with the first principal component of 
the module, termed the module eigengene (ME)[58]. 
KME are Module Membership values, also known as 
eigengene-based connectivity, and range from 0 
(indicating no connectivity) to +1 (high connectivity) or 
to -1 (inverse connectivity). The network was 
graphically depicted by exporting the TO weights into 
the program Gephi [62]. 
 
Statistical analysis 
 
Statistical analysis of patient survival rates was 
performed using SPSS v22 (IBM SPSS Inc.). The 
primary endpoint was death from cancer; survival time 
was measured from the date of diagnosis in the HNSCC 
cohort and date of surgery in the EAC cohort. Other 
causes of death were censored at the time of death. 
Kaplan-Meier plots (with Log-rank [Mantel-Cox] tests) 
were used to describe the risk of dying from cancer 
within the indicated stratification metrics, unless 
otherwise stated. 
 
Throughout the manuscript, all the experiments were 
performed at least 3 times and data are expressed as the 
mean +/- SEM of at least 3 replicates. Where 
appropriate, one way analysis of variance (ANOVA) 
was used to compare multiple groups. For comparisons 
between groups a two-tailed homoscedastic Student’s t-
test was used. A p value of < 0.05 was considered 
significant (*p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001). 
 
Immunocytochemistry, Western blotting, Real Time 
Quantitative PCR (primer sequences described in 
Supplementary Table S7), generation of Fibroblast 
Derived Matrices (FDMs), Transmission Electron 
Microscopy, collagen gel contraction, migration and 
TGF-β1 assays are described in the Supplementary 
Materials. 
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